« Page: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21 of 45. »
|
| Product | Alternate Name | Type | Strength | Quantity | Price (USD) | Buy Now | |
 |
Accupril |
quinapril |
Brand |
10mg |
90TAB |
$54.00 |
|
|
Accupril |
quinapril |
Brand |
20mg |
90TAB |
$60.00 |
|
|
Accupril |
quinapril |
Brand |
5mg |
90TAB |
$52.00 |
|
|
Accuretic |
quinapril/hctz |
Generic |
10/12.5mg |
90TAB |
$57.00 |
|
|
Accuretic |
quinapril/hctz |
Generic |
20/12.5mg |
90TAB |
$60.00 |
|
|
Accuretic |
quinapril/hctz |
Brand |
10/12.5mg |
90TAB |
$57.00 |
|
|
Accuretic |
quinapril/hctz |
Brand |
20/12.5mg |
60TAB |
$54.00 |
|
|
Accuretic |
quinapril/hctz |
Brand |
20/12.5mg |
90TAB |
$60.00 |
|
|
Aceon |
perindopril |
Brand |
2mg |
30TAB |
$67.00 |
|
|
Aceon |
perindopril |
Brand |
2mg |
60TAB |
$82.00 |
|
|
Aceon |
perindopril |
Brand |
2mg |
90TAB |
$102.00 |
|
|
Aceon |
perindopril |
Brand |
4mg |
30TAB |
$72.00 |
|
|
Aceon |
perindopril |
Brand |
4mg |
60TAB |
$97.00 |
|
|
Aceon |
perindopril |
Brand |
4mg |
90TAB |
$124.00 |
|
|
Actonel |
risedronate |
Generic |
35mg |
12TAB |
$55.00 |
|
|
Actonel |
risedronate |
Generic |
35mg |
16TAB |
$68.00 |
|
|
Actonel |
risedronate |
Brand |
35mg |
4TAB |
$92.00 |
|
|
Actonel |
risedronate |
Brand |
35mg |
12TAB |
$207.00 |
|
|
Actonel |
risedronate |
Brand |
35mg |
24TAB |
$357.00 |
|
|
Actonel |
risedronate |
Brand |
75mg |
2TAB |
$97.00 |
|
|
Actos |
pioglitazone |
Generic |
15mg |
28TAB |
$47.00 |
|
|
Actos |
pioglitazone |
Generic |
15mg |
84TAB |
$52.00 |
|
|
Actos |
pioglitazone |
Generic |
30mg |
28TAB |
$50.00 |
|
|
Actos |
pioglitazone |
Generic |
30mg |
84TAB |
$62.00 |
|
« Page: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21 of 45. »
|
|
-
2010-03-17 19:50:00
UBS Says Avandia lawsuits pose up to $6B risk to GSK -Ennislaw 03/15/2010 - The UBS (Union Bank of Switzerland) reported publicly last week that pharmaceutical giant GlaxoSmithKline PLC could end up liable for more than $6 billion in settlements and compensation for serious health complications caus ...
-
2010-03-17 14:32:00
Features: New Kernel, legless and prove of bugs; Full compatible with Joypad; Hit and Total Damage count; Strong blows (Critical) throws player or enemy away; Enemies and Allies with advanced AI; Allies can now, heal party members with skills or itens besides get dropped items on the ground; Ranged ...
-
2010-03-17 09:19:00
Ranbaxy Laboratories Ltd has entered into an agreement with the Japanese drug maker Takeda Pharmaceuticals for ending the patent litigation regarding diabetic drug Actos. Takeda has granted Ranbaxy,a non-exclusive royalty free license to its patent covering Actos.Ranbaxy would be able to launch the ...
-
2010-03-17 06:01:00
Israel was attacked in 1967, and in the process of defending itself, it pushed back the attackers and picked up considerably more land. Given that the 1949 borders were difficult to defend, keeping land captured as a result of an unprovoked war makes good strategic sense. If a country wins a war, es ...
-
2010-03-16 19:29:00
By Kurt R. Karst – FDA’s recent response to a 2009 citizen petition filed by Sandoz, Inc. concerning the appropriate certification to certain Orange Book-listed patents for Takeda’s ACTOS (pioglitazone HCI) Tablets and ACTOPLUS MET (pioglitazone HCl; metformin HCI) Tablets can be summed up in two (L ...
-
2010-03-16 00:03:00
Orlando Zapata Tamayo was a simple man who possessed a simple dream: to secure the freedom of Cuban prisoners-of-conscience who were being placed alongside common criminals in Cuba’s prisons. That is all. No calls for violence. No calls for revolution. He recognized an injustice and spoke out agains ...
-
2010-03-15 17:07:00
In 2004, we followed “The Vioxx Conundrum” as an example of the context, The Gaming of Nearly Everything. In September of that year, Merck pulled its $2.4 billion-per-year drug off the market after its own research showed the drug doubled the risk of heart attack and stroke. By 2008, Merck had agree ...
-
2010-03-15 15:46:00
Today, being diagnosed with diabetes does not mean what it used to. For many people, before more was learned about diabetes and how to best treat the condition, there weren’t many options. Today there are many types of diabetes treatment that may be suitable for you, some may include medication, whi ...
-
2010-03-14 08:34:00
3wM5A6 Aloha! and aspirin without prescription and http://www.tigblog.org/group/aspirinfda/#26 aspirin without prescription and 183 and
-
2010-03-14 08:10:00
Desculpem lá, mas não tenho tempo para traduzir. No fundo, é um debate sobre qual a idade limite para se ser considerado imputável e consciente pelos actos cometidos. Reparem que a morte de uma criança às mãos de outras, foi considerada desagradável. No fundo, uma outra versão da postura que conside ...
-
2010-03-14 04:35:00
Cross posted at Cubanita’s Thoughts Last week, I also received the stupid letter. A letter that tells me that within a week, I will be receiving another letter from the US Census. And these are the people the “progres” out there want me have handling my health care? Yeah… sure… OMDB (over my dead bo ...
-
2010-03-14 00:10:00
If you are looking for actos, we can help you. Buy online right now. DISCREET packaging, ANONYMOUS delivery. + Really amazing prices and Free bonuses! Discount system! + Free bonus pills for every order! + We are in business for years, so shoping is 100% safe!
-
2010-03-13 10:24:00
On March 8, the consumer advocacy group Public Citizen sent a letter to the U.S. Food and Drug Administration urging it to ban the diabetes drug Avandia. In the letter, Public Citizen Director Sidney Wolfe MD notes the recent FDA recall of products that contain hydrolyzed vegetable protein because o ...
-
2010-03-12 17:55:00
Normal 0 false false false MicrosoftInternetExplorer4 NaProTechnology is a brand new health-related science whereby the diagnostic and therapeutic energies from the physician are directed toward the identification and medication of reproductive and gynecologic issues in the method that is aimed at r ...
-
2010-03-11 14:20:00
Tide Is Turning Back в пользу Такеды? is a post from: Мой блог EP Vantage submits: With so many high-profile pipeline setbacks over the past couple of years, could the tide be turning back in Takeda’s ( TKPHF.PK) favor with regard to one of its biggest and most valuable products? Wednesday’s patent ...
|
|